Drug Type Small molecule drug |
Synonyms isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, Nisoldipine (JAN/USAN/INN), BAY-K-5552 + [13] |
Target |
Mechanism Cav2.1 inhibitors(calcium voltage-gated channel subunit alpha1 A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (02 Feb 1995), |
Regulation- |
Molecular FormulaC20H24N2O6 |
InChIKeyVKQFCGNPDRICFG-UHFFFAOYSA-N |
CAS Registry63675-72-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00618 | Nisoldipine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | US | 02 Feb 1995 |
Phase 4 | 48 | ncjzxgiggw(estuyqwyjh) = rkuqjpfenf bexfwcfjki (snmawxsxai ) View more | - | 01 Dec 2000 | |||
ncjzxgiggw(estuyqwyjh) = zjkjnsnlyc bexfwcfjki (snmawxsxai ) View more |